These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 17882408)

  • 1. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.
    Vriesendorp R; Cohen A; Kristanto P; Vrijens B; Rakesh P; Anand B; Iwebor HU; Stiekema J
    Eur J Clin Pharmacol; 2007 Dec; 63(12):1115-21. PubMed ID: 17882408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication adherence in patients with HIV infection: a comparison of two measurement methods.
    Melbourne KM; Geletko SM; Brown SL; Willey-Lessne C; Chase S; Fisher A
    AIDS Read; 1999 Aug; 9(5):329-38. PubMed ID: 12737122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of an adherence clinic on behavioral outcomes and virologic response in treatment of HIV infection: a prospective, randomized, controlled pilot study.
    Rathbun RC; Farmer KC; Stephens JR; Lockhart SM
    Clin Ther; 2005 Feb; 27(2):199-209. PubMed ID: 15811483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting.
    Fairley CK; Permana A; Read TR
    HIV Med; 2005 Sep; 6(5):366-9. PubMed ID: 16156886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of short-term success of antiretroviral therapy in HIV infection.
    Oette M; Kroidl A; Göbels K; Stabbert A; Menge M; Sagir A; Kuschak D; O'hanley T; Bode JG; Häussinger D
    J Antimicrob Chemother; 2006 Jul; 58(1):147-53. PubMed ID: 16687458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.
    Protopopescu C; Raffi F; Roux P; Reynes J; Dellamonica P; Spire B; Leport C; Carrieri MP;
    J Antimicrob Chemother; 2009 Sep; 64(3):599-606. PubMed ID: 19602563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of individual cognitive behaviour intervention on adherence to antiretroviral therapy: prospective randomized trial.
    Weber R; Christen L; Christen S; Tschopp S; Znoj H; Schneider C; Schmitt J; Opravil M; Günthard HF; Ledergerber B;
    Antivir Ther; 2004 Feb; 9(1):85-95. PubMed ID: 15040540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates.
    Wohl DA; Stephenson BL; Golin CE; Kiziah CN; Rosen D; Ngo B; Liu H; Kaplan AH
    Clin Infect Dis; 2003 Jun; 36(12):1572-6. PubMed ID: 12802758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment.
    Andrade AS; McGruder HF; Wu AW; Celano SA; Skolasky RL; Selnes OA; Huang IC; McArthur JC
    Clin Infect Dis; 2005 Sep; 41(6):875-82. PubMed ID: 16107989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between pharmacy medication refill-based adherence rates and cd4 count and viral-load responses: A retrospective analysis in treatment-experienced adults with HIV.
    Townsend ML; Jackson GL; Smith R; Wilson KH
    Clin Ther; 2007 Apr; 29(4):711-6. PubMed ID: 17617294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring medication adherence: are missed doses reported more accurately then perfect adherence?
    Wagner GJ; Rabkin JG
    AIDS Care; 2000 Aug; 12(4):405-8. PubMed ID: 11091773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HAART with didanosine once versus twice daily: adherence and efficacy.
    Roca B; Lapuebla C; Vidal-Tegedor B
    Int J Infect Dis; 2005 Jul; 9(4):195-200. PubMed ID: 15964537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations.
    Bova CA; Fennie KP; Knafl GJ; Dieckhaus KD; Watrous E; Williams AB
    AIDS Behav; 2005 Mar; 9(1):103-10. PubMed ID: 15812617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
    Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
    Ophthalmology; 2009 Feb; 116(2):191-9. PubMed ID: 19084273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of a stage of change instrument in assessing medication adherence in indigent patients with HIV infection.
    Rathbun RC; Farmer KC; Lockhart SM; Stephens JR
    Ann Pharmacother; 2007 Feb; 41(2):208-14. PubMed ID: 17213294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing adherence to HAART: a pilot program of modified directly observed therapy.
    Stenzel MS; McKenzie M; Mitty JA; Flanigan TP
    AIDS Read; 2001 Jun; 11(6):317-9, 324-8. PubMed ID: 11449925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients.
    Turner BJ
    J Infect Dis; 2002 May; 185 Suppl 2():S143-51. PubMed ID: 12001036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily dosing of nevirapine in HAART.
    Clotet B
    J Antimicrob Chemother; 2008 Jan; 61(1):13-6. PubMed ID: 18006524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting and monitoring antiretroviral adherence.
    Gross R
    LDI Issue Brief; 2007; 13(2):1-4. PubMed ID: 18354853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Simply forgot' is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence.
    Barfod TS; Sørensen HT; Nielsen H; Rodkjaer L; Obel N
    HIV Med; 2006 Jul; 7(5):285-90. PubMed ID: 16945072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.